Per Multiple Sclerosis News Today, "Treatment with Ocrevus (ocrelizumab) has superior or comparable effectiveness and a similar safety profile to other available disease-modifying treatments (DMTs) for treating relapsing multiple sclerosis (MS), according to a new review study."
Ocrevus has superior or comparable effec... - My MSAA Community
Ocrevus has superior or comparable effectiveness and a similar safety profile to other available DMTs for RRMS
Written by
sashaming1
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
I saw this article and since I’m on Ocrevus thought 👍👍👍 but I also read that 3 of the 6 authors worked for Genentech/Roche. So a bit of a conflict of interest 🤷♀️
Not what you're looking for?
You may also like...
Promising research: estrogen to regenerate myelin?
searchers-work-to-advance-treatment-targeting-source-of-multiple-sclerosis/
Cartoon memes sum up most MS symptoms 😊🙁
http://positivelivingwithms.com/an-illustrated-view-of-multiple-sclerosis/#.WOn9rcZMDCY.mailto...
Anyone have high blood pressure? It's the one thing I don't have thank goodness!
com/2018/07/23/hypertension-common-in-multiple-sclerosis-patients-compared-to-general-public-study-r
J.K. Rowling Donates $18.8 Million to Research Into the Treatment of Multiple Sclerosis
https://time.com/5676636/jk-rowling-donation-multiple-sclerosis-research/?fbclid=IwAR0p6XtNJfL-BxWvK
Some Hope - World Free of MS
-biontech-multiple-sclerosis-20210112-z5huyyfgtfhvvlkwkobxmthrz4-story.html
https://theweek.com/spee